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Abstract
Gene products of recombinant replication-deficient adenovirus vectors of the first generation (Ad vector) can induce cell
cycle dysregulation and apoptosis after infection in eukaryotic cells. The mechanisms underlying this complex process are
largely unknown. Therefore, we investigated the regulation of the pRb/E2F-1 complex, which controls transition from G0/G1
to S phase of the cell cycle. As Ad vector infection results in a decrease in the number of cells in G0/G1 phase of the cell cycle,
we observed a decline of the pRb protein level and, surprisingly, also a decrease of the E2F-1 protein and mRNA level in
infected cell lines. Furthermore, in contrast to the reduction of cells in the G0/G1 phase we observed increased protein levels
of p53 and p21 proteins. However, as experiments in p53 deficient cell lines indicated, the decrease of pRb and E2F-1 is
independent of p53 and p21 expression. Moreover, results obtained with Rb deficient cell lines indicated that the reduced
E2F-1 expression is independent of pRb. These results suggest that Ad vector-induced cell cycle dysregulation is associated
with a specific downregulation of E2F-1 independent of Rb and p53 genomic status of cells. ß 2002 Elsevier Science B.V.
All rights reserved.
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1. Introduction
Recombinant replication-de¢cient adenovirus-
based gene transfer vectors of the ¢rst generation
(Ad vectors) are one of the most powerful and e⁄-
cient means to transfer genetic material. In Ad vec-
tor, the E1 region of the adenovirus genome which is
responsible for induction of viral replication has been
deleted to prevent virus replication [1^3]. This dele-
tion generates space for an expression cassette which
allows transgene expression for an extended period
[4,5]. However, the Ad vector still carries most of the
adenoviral genes. Whereas they stimulate in general
the host cell metabolism in favor of foreign gene
expression, speci¢c adenovirus gene products inter-
fere with the cell cycle of the infected cell [2,6]. For
instance, the E4orf6/7 protein binds to E2F proteins
during the early phase of infection to stimulate E2
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promoter activity [7,8]. Moreover, the E4orf6 protein
can bind to and inactivate p53 to control one of the
major checkpoints of apoptosis and cell cycle regu-
lation [9].
One of the most important checkpoints of the cell
cycle in eukaryotic cells is the restriction point
(R-point) which controls transition from G0/G1
phase to S phase [10]. Whereas the R-point is regu-
lated by many factors, the ultimate substrate in this
process is the Retinoblastoma protein (pRb) [11]. Its
major activity is supposed to be sequestration or in-
activation of the transcription factor E2F which is
required for activation of S-phase genes [12]. The
E2F family of transcription factors comprises a
group of closely related proteins (E2F-1 through
-5). One of the best characterized gene of the E2F
family is E2F-1. During G0/G1 phase of the cell cycle
hypophosphorylated pRb binds E2F-1 protein and
this complex actively represses transcription from
E2F sites in several promoters [13,14]. For transition
from G0/G1 to S phase, phosphorylation of pRb by
G1 cyclin/cyclin-dependent kinase (cdk) complexes
results in release of active E2F-1 protein [12,15].
This active protein directs due to its function as tran-
scription activator the timely expression of cell cycle-
controlling genes whose products are involved in
DNA replication [16].
Several studies have shown that changes in the
expression level of pRb and E2F-1 protein can lead
to dysregulation of the cell cycle. De¢ciency of pRb
leads to inappropriate S phase entry, activation of
E2F-response genes and apoptosis [17]. On the other
hand, introduction of wild-type Rb gene into cells
lacking functional pRb suppresses cell growth and
apoptosis after DNA damage [18,19]. In contrast,
overexpression of E2F-1 induces accumulation of
cells in S and G2/M phases and leads to apoptosis
[20].
Because several studies have shown that Ad vector
can induce cell cycle alterations [21,22], we analyzed
the e¡ect of Ad vector infection on expression of
pRb and E2F-1 of the host cell. We found that
Ad vector infection induces a decrease of pRb and
also a decline of E2F-1 protein and mRNA expres-
sion. The downregulation of pRb and E2F-1 was
independent of the p53 genomic status and the de-
cline of E2F-1 was furthermore not dependent on the
presence of pRb. Our results show that Ad vector-
induced cell cycle dysregulation is associated with
speci¢c changes in the expression of cell cycle regu-
latory proteins.
2. Materials and methods
2.1. Cell lines and cell culture
All cell lines used were purchased from ATCC.
The human colon carcinoma cell lines LoVo,
LS174T, SW620, human breast cancer cell line
BT549, cervix cancer cell line C33A, lung cell
(NSCLC) cancer line H1299 and 293 cells (human
embryonic kidney cells) were maintained in DMEM
or RPMI 1640 (LS174T, SW620, H1299), supple-
mented with 10% FCS (fetal calf serum) and 2 mM
glutamine at 37‡C, 5% CO2 in a humidi¢ed atmo-
sphere. For experiments, cells were seeded, treated
and analyzed as indicated.
2.2. Recombinant adenovirus vectors
The recombinant Ad vector AdRSV-hAAT.2 car-
rying the cDNA of the human K1-antitrypsin driven
by the Rous-Sarcoma-Virus promoter was a gift
from M. Kay (Department of Genetics, Stanford
University, Palo Alto, CA, USA). The recombinant
Ad vector AdCLX.Null without expression cassette
and AdRSV.L-Gal, carrying the cDNA of L-galacto-
sidase, were a gift from R. Crystal (Cornell Univer-
sity Medical College, New York, NY). Vectors were
propagated on 293 cells and puri¢ed by cesium chlo-
ride density centrifugation, titered by plaque assay
and stored at 380‡C [5]. Multiplicity of infection
(MOI) resulting in equal levels of infection in the
di¡erent cell lines were determined by infecting the
cells with AdRSV.L-Gal carrying the reporter gene
L-galactosidase. Infection of cells was performed for
1.5 h at 37‡C in serum free medium. After 1 day of
infection, cells were ¢xed and stained for L-galacto-
sidase (L-Gal) activity.
2.3. Western blotting
Cell extracts were lysed on ice (50 mM HEPES
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(pH 7.5), 200 mM NaCl, 1 mM EDTA, 2.5 mM
EGTA, 10% glycerol, 0.1% Tween 20, 10 mM L-glyc-
erophosphate, 1 mM DTT, 0.1 mM PMSF, 5 Wg/ml
leupeptin). Protein concentrations were determined
by DC Protein Assay (Bio-Rad). For Western blot-
ting, 10 Wg protein per lane were resolved by sodium
dodecyl sulfate^polyacrylamide gel electrophoresis
(SDS^PAGE) and transferred onto nitrocellulose
membranes (Hybond-N, Amersham) by standard
procedures. Primary monoclonal antibodies against
Rb (G3-245), E2F-1 (KH95/E2F), p53 (DO-1) and
p21 (SX118) were purchased from Pharmingen and
the antibody against L-actin (N 350) from Amer-
sham. The biotinylated secondary antibody was de-
rived from Vector Laboratories. In all cases detection
was performed with streptavidin coupled peroxidase
and ECL (Amersham).
2.4. Assessment of cell cycle distribution by
FACS analysis
For FACS analysis 8U105 cells were seeded
as triplicates in 10-cm dishes, allowed to adhere over-
night and infected with Ad vectors at the indicated
multiplicity of infection (MOI). The cells were
harvested at the times indicated, were stained
with FITC-conjugated Annexin V and propidium
iodide (PI) using the Annexin V kit (Immunotech)
and analyzed by £ow cytometry (FACScan, Bec-
ton Dickinson) for the presence of viable (Annexin
V- and PI-negative) and apoptotic (Annexin V-pos-
itive) cells which include both, primary (PI-negative)
and secondary (PI-positive), apoptotic subpopula-
tions.
To study cell cycle distributions, samples (5U105
cells) were ¢xed and permeabilized by addition of
2 ml of ice-cold 70% ethanol for 1 h at 4‡C. After
washing, the cells were resuspended in 0.5 ml PBS
containing 50 mg/ml PI, pH 7.5. Following treatment
with 10 Wl of 10 mg/ml RNase (type I-A; Roche
Diagnostics) for 30 min at room temperature in the
dark, the cells were stored at 4‡C until analysis by
£ow cytometry. Cell cycle analysis was performed
using either CellQuest software (Becton Dickinson)
or ModFit LT (Verity, Topsham, ME, USA). Cell
aggregates were excluded from the analysis by using
the Doublet Discriminating Module (DDM, Becton
Dickinson).
2.5. Semiquantitative reverse transcriptase^
polymerase chain reaction (RT^PCR)
Total RNA was isolated from 1U106 cells infected
with Ad vector or mock infected using RNeasy Mini
kit (Qiagen). The extracted RNA was quanti¢ed by
260 nm and 1 Wg was subjected to DNase I digestion
(Gibco-BRL) at room temperature for 15 min.
DNase I was heat-inactivated by addition of
EDTA (2,5mM) and incubation for 15 min at
65‡C. After DNase digestion RNA was subjected
to reverse transcription using oligo(dT) primer fol-
lowing the protocol described in a Reverse Tran-
scription System kit (Promega). Samples were ampli-
¢ed by PCR for Rb and E2F-1. GAPDH was used as
control. The primer used for ampli¢cation were as
follows: Rb forward 5P-CCGGAGGACC-TGCC-
TCTCGT-3P, Rb reverse 5P-AACGACATCTCATC-
TAGGTC-3P, E2F forward 5P-ACCTTCGTAGC-
ATTG-CAGACC-3P, E2F reverse 5P-TTCTTGC-
TCCAGGCTGAGTAG-3P, GAPDH forward 5P-
GCAGGGGGG-AGCCAAAAGGG-3P, GAPDH
reverse 5P-TGC-CAGCCCCAGCGTCAAAG-3P.
Each ampli¢cation mixture (20 Wl) containing 1 Wl
cDNA, 2 Wl Reaction-Bu¡er (Promega), 1 U Taq
polymerase (Promega), 200 WM dNTP each, and 10
pg forward and reverse primers each. The optimized
PCR conditions were one cycle denaturation at 94‡C
for 2 min, followed by gene speci¢c cycles (Rb and
E2F-1: 30 cycles; GAPDH: 22 cycles) of denatura-
tion at 94‡C for 30 s, gene-speci¢c annealing (Rb:
55‡C; E2F-1: 58‡C; GAPDH: 62‡C) for 30 s, and
extension at 72‡C for 30 s. The ampli¢cation cycles
were followed by an additional extension at 72‡C for
7 min. The PCR products were run on 2% agarose
gel with ethidium bromide staining. The intensity for
each band was determined using the Gel Doc System
(Bio-Rad).
2.6. UV inactivation of Ad vector
Virus (AdRSV.L-Gal) was diluted in 2 ml serum-
free medium in a six-well plate. The plate was placed
on a UV table and irradiated for 30 min (302 nm).
One ml of serum-free medium containing UV inacti-
vated Ad vector was used to infect cells as described
above. As control we used virus, which was placed in
the six-well plate for 30 min without UV irradiation.
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After 1 day of infection, cells were ¢xed and stained
for L-galactosidase activity.
3. Results
3.1. E¡ect of Ad vector on cell cycle regulation and
induction of apoptosis
Gene products of the Ad vector can alter the cell
cycle regulation of the host cell after infection [23^
25]. To further examine the underlying molecular
mechanisms, LoVo cells were infected with an Ad
vector carrying the human K1-antitrypsin gene
(AdRSV-hAAT.2) as reporter gene or with an Ad
vector without an expression cassette (AdCLX.Null).
Seventy-two hours after infection, cells were counted
and subjected to analysis of cell cycle distribution.
Consistent with earlier reports cell cycle analysis
showed a substantial decrease in the relative number
of cells in the G0/G1 phase and an increase in the
relative number of cells in the G2/M phase of the cell
cycle (Table 1). The di¡erences in G0/G1 and G2/M
phases between mock-infected cells and cells infected
with the Ad vectors were statistically signi¢cant. Par-
allel to the changes in cell cycle distribution, we ob-
served a signi¢cant increase (P6 0.05) in the number
of apoptotic cells (mock: 4.7 þ 0.6%; AdRSV-
hAAT.2: 11.0 þ 1.0%; AdCLX.Null : 7.8 þ 1.2%).
Similar results were obtained with the Ad vector car-
rying the cDNA for L-galactosidase under the con-
trol of the RSV promoter (Table 2). These data in-
dicate that Ad vector infection induces dysregulation
of the cell cycle, and that this is independent of the
cDNA contained in the expression cassette of Ad
vector.
3.2. E¡ect of Ad vector on expression of
G1 regulatory proteins
A variety of DNA viruses like the adenovirus use
the transcription machinery of the host cell to repli-
cate their own genome by activating cell cycle pro-
gression due to overriding the G1 checkpoint of cell
cycle regulation [2,6]. In this context G1 regulatory
proteins like p53 and pRb are one of the main tar-
gets for adenovirus gene products leading to inacti-
vation of the G1 checkpoint. Therefore, we analyzed
the expression of G1 regulatory proteins after infec-
tion with AdRSV-hAAT.2 and AdCLX.Null. West-
ern blot analysis in Ad vector-infected LoVo cells
demonstrated that the expression of endogenous
p53 was increased when compared with mock-in-
fected cells (Fig. 1A). Consequently, we also ob-
served an increase of p21 which can be transcription-
ally activated by p53 [26]. One of the important
functions of p53-induced p21 expression is the arrest
of cells in G1 mediated by pRb [27]. However, as
Table 2
Cell cycle distribution of LoVo cells and number of L-galactosidase-positive cells infected with AdRSV.L-Gal after UV inactivation
Mock AdRSV.L-Gal AdRSV.L-Gal (UVa)
G0/G1 71.9 þ 2.4 50.4 þ 6.8* 69.5 þ 3.7
S 18.8 þ 3.6 31.2 þ 7.2* 21.1 þ 2.9
G2/M 9.3 þ 2.1 18.4 þ 7.1* 9.4 þ 4.1
L-Gal-positive cells 0% s 95% 6 1%
LoVo cells were mock infected, or infected with 50 MOI of native AdRSV.L-Gal and after UV irradiation. Cells were harvested after
72 h of infection and DNA content was determined by FACS analysis. Percentages of cells in G0/G1, S and G2/M phases are derived
from DNA histograms. Data are mean þ S.D. (n = 3). *Signi¢cantly di¡erent to mock (P6 0.05) using Student’s t-test.
aUV inactivated.
Table 1
Cell cycle distribution of LoVo cells infected with Ad vectors
Mock AdRSV.hAAT AdCLX.Null
G0/G1 61.3 þ 5.2% 35.8 þ 1.7%* 43.7 þ 4.8%*
S 28.2 þ 6.7% 33.6 þ 1.7% 36.5 þ 3.2%
G2/M 10.6 þ 1.5% 30.6 þ 2.0%* 19.8 þ 5.3%*
LoVo cells were mock infected, or infected with 50 MOI of
AdRSV-hAAT.2, or AdCLX.Null. Cells were harvested after
72 h of infection and the DNA content was determined by
FACS analysis. Percentages of cells in G0/G1, S and G2/M
phases are derived from DNA histograms. Data are
mean þ S.D. (n = 3). *Signi¢cantly di¡erent to mock (P6 0.05)
using Student’s t-test.
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described, Ad vector induces a decrease in the frac-
tion of cells in G1 phase. Therefore we also analyzed
the protein level of pRb, which should be downregu-
lated if cells are lost in G1 [11]. Infection of LoVo
cells with Ad vectors induced a reduction in the level
of pRb (Fig. 1A). Since the loss and/or inactivation
of pRb can lead to overexpression of E2F-1 [28,29],
we next investigated the protein expression of E2F-1,
which is required for activation of S-phase genes [12].
Interestingly, in contrast to the well known upregu-
lation of E2F-1 during progression of transition of
G1 to S phase, we observed a dramatic decline of
E2F-1 protein expression after Ad vector infection
(Fig. 1A). The observed e¡ect of decreased pRb
and E2F-1 protein levels after Ad vector infection
was dependent on the dose (Fig. 2) and on the du-
ration of infection (data not shown). These results
indicate that infection of cells with the Ad vector is
associated with downregulation of the protein levels
of pRb and E2F-1. Further, these changes in the
expression of cell cycle regulatory factors were also
independent of the cDNA contained in the expres-
sion cassettes of the Ad vector.
Fig. 2. Expression of pRb and E2F-1 in LoVo cells infected
with various doses of Ad vector. LoVo cells were infected with
increasing doses (0, 1, 10, 30, 50 and 100 MOI) of AdRSV-
hAAT.2. After 72 h incubation, cells were harvested and pro-
tein expression of pRb and E2F-1 was examined by Western
blot analysis as described in Fig. 1.
Fig. 1. Expression of G1 regulatory proteins in LoVo cells in-
fected with Ad vectors. LoVo cells were (A) mock infected or
infected with 50 MOI of AdRSV-hAAT.2, or AdCLX.Null,
and (B) infected with 50 MOI of AdRSV.L-Gal or of
AdRSV.L-Gal after UV irradiation. After 72 h of infection
£oating and adherent cells were harvested, combined and sub-
jected to Western blot analysis for protein levels of pRb, E2F-
1, p53 and p21. Equal amounts (10 Wg) of cellular protein from
each sample were separated by SDS^PAGE (8% for pRb, p53
and E2F-1, 15% for p21). After electrophoresis, proteins were
transferred onto a nitrocellulose membrane. The membrane was
probed with monoclonal anti-human pRb, E2F-1, p53 and p21
antibodies and protein bands were visualized. Multiple bands of
pRb and E2F-1 represent di¡erent phosphorylation states.
L-Actin was used to control protein loading. *UV inactivated.
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3.3. UV-inactivated Ad vector has no e¡ects on cell
cycle progression and its regulation
In order to examine whether the uptake of Ad
vector particles itself may have the potential to in-
duce cell cycle changes, we inactivated the viral DNA
by exposition to UV light. Infection of LoVo cells
with an Ad vector containing the cDNA of L-galac-
tosidase showed that enzyme activity was lost after
UV inactivation of Ad vector. Whereas about 95% of
cells infected with the control vector were stained,
less than 1% of cells infected with UV-inactivated
vector showed L-galactosidase activity (Table 2).
This means that the transcriptional activity of Ad
vector is abrogated and any observed e¡ects are in-
dependent of viral gene expression.
Analysis of cell cycle after infection of cells with
UV inactivated Ad vector showed no di¡erence in
the cell cycle distribution compared with mock-in-
fected cells, whereas the untreated vector again
showed a signi¢cant decrease in G0/G1 phase and
an arrest in G2 (Table 2). Further, the Ad vector-
induced changes in the expression of cell cycle regu-
lating proteins such p53, p21, pRb, and E2F-1 were
abrogated by UV inactivation (Fig. 1B). These re-
sults indicate that adenoviral gene expression is nec-
essary for the induction of cell cycle changes.
3.4. Role of p53/p21 pathway on downregulation of
pRb and E2F-1 by Ad vector infection
We found an increase in the level of p53 protein
expression in p53 wild-type (wt) LoVo cells after Ad
vector infection. Because p53 can indirectly inhibit
the E2F-1 transcriptional activity by maintaining
pRb in its hypophosphorylated form [30], we were
interested to see if the Ad vector-induced decrease of
pRb and E2F-1 protein expression might be related
to the genetic status and/or the presence of p53. To
this end, we infected the p53-negative cell line H1299
with the Ad vector. As observed in p53-wt LoVo
cells, we noted a decrease of pRb and E2F-1 protein
levels after infection with an equivalent dose of Ad
vector (Fig. 3). The same results were obtained when
SW 620, a cell line which overexpresses mutated p53
was used (data not shown).
The protein expression of p21 which can be tran-
scriptionally activated by p53 is increased in LoVo
cells infected with Ad vector. Because transcription
of the p21 gene can also be activated by p53-inde-
pendent mechanisms [31], we also analyzed the pro-
tein level of p21 in p53-de¢cient cells after Ad vector
infection. In contrast to wt p53 LoVo cells we found
no di¡erence in the protein level of p21 between Ad
vector and mock-infected H1299 cells (Fig. 3). In
mutant-type (mt) p53 cells such as BT549, C33A or
SW620 which either do not express p21 or only at
low levels, we also observed no di¡erence in the pat-
tern of expression of p21 between Ad vector and
mock-infected cells (data not shown). This demon-
strates that the decrease of pRb and E2F-1 protein
levels after Ad vector infection is not dependent on a
functional p53/p21 pathway.
3.5. E¡ect of Ad vector on mRNA levels of Rb and
E2F-1
To investigate whether the changes observed in the
Rb and E2F-1 protein levels are paralleled by similar
changes in the level of mRNA, we determined
mRNA expression of Rb and E2F-1 in infected
LoVo cells by semi-quantitative RT^PCR. We de-
Fig. 3. pRb and E2F-1 expression in p53-negative cells infected
with Ad vector. The p53-negative cell line H1299 was mock in-
fected or infected with 25 MOI AdRSV-hAAT.2. After 96 h in-
cubation, cells were harvested and expression of pRb, E2F-1,
p53 and p21 was examined by Western blot analysis as de-
scribed in Fig. 1.
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tected that the mRNA level of E2F-1 was decreased
in Ad vector-infected LoVo cells to about 50% of the
level in uninfected control cells, whereas the mRNA
level of Rb remained unchanged (Fig. 4). Investiga-
tions with the p53-negative cell line H1299 showed
the same results (data not shown). This demonstrates
that E2F-1 mRNA is downregulated in Ad vector-
infected cells whereas pRb appears to be a¡ected
only at the level of protein.
3.6. In£uence of pRb expression on E2F-1
downregulation
The mRNA expression of pRb and E2F-1 indi-
cated that both genes are di¡erently transcriptionally
regulated. Because pRb can regulate the E2F-1 ex-
pression [11,12], we next examined whether downre-
gulation of E2F-1 protein depends on expression of
pRb. To this end, we investigated the in£uence of Ad
vector infection on the level of E2F-1 protein expres-
sion in two pRb defective cell lines; BT549, which is
Rb deleted and C33A, which expresses a smaller and
inactive form of pRb at a very low level. We ob-
served in these cells the same cell cycle alterations
as in pRb-positive cells (data not shown). Further,
similar to the results in cell lines expressing intact
pRb, infection of cells carrying deleted or inactive
pRb with Ad vector also leads to a decline of E2F-
1 protein expression (Fig. 5). These observations sug-
gest that the downregulation of E2F-1 after infection
with Ad vector occurs independently of pRb.
4. Discussion
In our study we investigated the in£uence of Ad
vector of the ¢rst generation on the protein complex
of pRb and E2F-1, known to be the ultimate sub-
strate in regulation of transition from G0 to G1
phase of the cell cycle. Consistent with previous stud-
ies [21,22], we observed in our study a decrease in the
number of cells in the G0/G1 phase and simulta-
neously an arrest of cells in G2/M after infection
with Ad vector, suggesting that cell cycle regulation
may be altered during infection. We found that these
cell cycle changes were accompanied by a decrease of
pRb and E2F-1 protein levels. Further, we observed
an upregulation of p53 and p21 in p53-wt cells.
The decrease of pRb protein expression was ex-
pected, because downregulation of pRb by viral
products is not unusual in order to promote cellular
transcription and viral replication. For example, the
SV40 large T antigen [32], HPV16 E7 oncoprotein
[33], and the adenovirus E1A protein [34], bind to
pRb and inhibit its tumor suppressor function. The
Epstein^Barr virus (EBV) immediate-early protein
BRLF1 downregulates pRb and induces transition
of G1 to S phase [29]. As we used E1-de¢cient ad-
enovirus, our results strongly indicate that adenoviral
proteins other than E1A can also cause, directly or
indirectly, the loss of pRb and, consequently, the
function of pRb in the G1^S phase transition. More-
over, pRb has been found to be important in the
regulation of G2/M transition [35,36]. However, we
Fig. 5. Expression of E2F-1 protein in pRb-negative cells in-
fected with Ad vector. The Rb-negative cell lines C33A and
BT549 were mock infected or infected with AdRSV-
hAAT.2(125 MOI/C33a, 80 MOI/BT549). Cells were harvested
96 h after infection and subjected to Western blot analysis for
the protein level of E2F-1 as described in Fig. 1.
Fig. 4. Rb and E2F-1 mRNA expression in LoVo cells infected
with Ad vector. LoVo cells were mock infected or infected with
AdRSV-hAAT.2 as described in Fig. 1. After 72 h cells were
harvested and total RNA was isolated. Steady-state level of Rb
and E2F-1 mRNA was determined by semi-quantitative RT^
PCR. GAPDH was used as control. The data presented are
representative of three samples.
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found the observed cell cycle changes also in pRb-
negative cells. This fact shows that Ad vector-in-
duced cell cycle dysregulation is not dependent on
pRb expression.
As the decreased level of pRb was paralleled by an
increase in protein levels of p53 and p21 in cells ex-
pressing wild-type p53, its loss during Ad vector in-
fection was suggested not to be caused by general
protein degradation. Moreover, this reduced pRb
level may explain why after Ad vector infection the
activated p53/p21 pathway does not result in G1 ar-
rest of the cell cycle [37]. P21 induces G1 arrest
through inactivation of the cyclin-dependent kinase
2 (cdk2), which is therefore blocked to phosphorylate
pRb. The resulting hypophosphorylated pRb pre-
vents cell cycle transition from G1 to S phase [30].
Because Ad vector infection induces a loss of the
ultimate substrate, i.e., the pRb protein, an upregu-
lated p53/p21 pathway is functionally insu⁄cient to
mediate G1 arrest.
The major activity of pRb during cell cycle regu-
lation is to control the R-point by sequestration or
inactivation of the transcription factor E2F-1, which
is required for S-phase entry [11,12]. In the G0/G1
phase E2F-1 is inactivated by binding to hypophos-
phorylated pRb. Inactivation of pRb by phosphory-
lation and/or destruction results in liberation of free
active E2F-1 which in turn activates expression of
genes involved in the G1 to S phase transition. This
suggests that the phenomenon of reduced fraction of
cells in G0/G1 may be easily explained by elevated
levels of liberated E2F-1 after loss of pRb. However,
we unexpectedly found a dramatic decrease of E2F-1
expression in the infected cells. An explanation for
this observation of a reduced G0/G1 population in
spite of downregulated E2F-1 could be that other
members of the E2F protein family might substitute
for E2F-1 [38] or other mediators can promote the
transition from G0/G1 into S phase. In fact, whereas
E2F-1 is one of the most prominent key regulators
for S-phase entry, recent studies demonstrated that
ectopic expression of cyclin/cdk complexes can in-
duce transition from G0/G1 to S phase in the absence
of free E2F-1 [39]. Since Wersto et al. found that
cyclin proteins such as cyclins A, B1, and D are
elevated in Ad vector-infected cells [21], it is conceiv-
able that rather than E2F-1, these cyclins with their
associated cdks are responsible for the cell cycle pro-
gression leading to a reduced fraction of cells in
G0/G1.
The increase of the proportion of cells in the G2/M
phase is also a prominent e¡ect of Ad vector infec-
tion. Normally, during S phase cyclin A binds to
E2F-1 which results in inhibition of E2F-1 DNA-
binding activity [40]. This inhibition of E2F-1 is im-
portant for correct cell cycle progression [41]. The
unscheduled presence of active E2F-1 or the induc-
tion of E2F-1 expression in cells induces a decline in
the G1 population with concomitant increase in the S
and G2/M population followed by apoptosis [42,43].
However, we observed a decrease of E2F-1. There-
fore, we suppose that the G2/M arrest of cells is not
directly caused by the decline of E2F-1.
The mechanism causing the decrease of E2F-1 and
its physiological role after Ad vector infection are at
present unclear. Alterations of cell cycle in response
to DNA damage are often associated with altered
expression of p53/p21 [44]. Therefore, we analyzed
whether E2F-1 downregulation in Ad vector-infected
cells is associated with activation of p53/p21. How-
ever, we also observed a decrease of E2F-1 expres-
sion in Ad vector-infected p53-de¢cient cells. There-
fore, we conclude that the downregulation of E2F-1
in Ad vector-infected cells is not dependent on p53
and p21 protein expression.
Overexpression of E2F-1 has been shown to lead
to cell cycle dysregulation and to induction of apo-
ptosis [20]. All adenoviral interference with the host
cell cycle described so far has pointed to the induc-
tion of E2F-1 to promote viral replication [7,8].
However, we observed a decrease of E2F-1 mRNA
and protein which is associated with alterations of
cell cycle distribution and induction of apoptosis.
Therefore, it is possible that the downregulation of
E2F-1 is a reaction of the cell in order to prevent
inappropriate cell cycle progression. This process is
counteracted by gene products of the E1 region in
wild-type adenovirus and is detectable only in E1-
deleted recombinant vectors. This mechanism might
be an equivalent to upregulation of p53 and p21 after
DNA damage which both serve to arrest the cell
cycle at several important checkpoints [37,45]. Obser-
vations in UV-irradiated BUdR-sensitized cells
showed an upregulation of p53 and p21 and also a
decrease of E2F-1 protein expression [46].
Nevertheless, the fact is that in infected cells the
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decrease of E2F-1 cannot maintain the cells in G0/G1
phase and does not protect against apoptosis. It is
likely that the Ad vector is still able to override the
protective mechanisms of the cell. Thus, further in-
vestigations of E2F-1 regulation after Ad vector in-
fection will give more information about the nature
of cell cycle control and may help to understand
cytotoxic side e¡ects of ¢rst-generation Ad vector,
and may aid the design of improved Ad vectors.
Acknowledgements
The authors would like to thank Dr. Ronald Crys-
tal (Cornell University, New York, USA) and Dr.
Michael Strauss (Max Delbru«ck Center for Molecu-
lar Medicine, Berlin, Germany) for generously pro-
viding the adenoviral vectors. Furthermore, we
would like to acknowledge Margret Gries and Petra
Pierschalek for their technical assistance. This work
was supported by a grant of the Fo«rderverein fu«r
Pneumologie (Leipzig, Germany) and BMBF (BEO/
31/-31P2450).
References
[1] T. Shenk, J. Flint, Adv. Cancer Res. 57 (1991) 47^85.
[2] T. Shenk, in: B.N. Fields (Ed.), Fields Virology, Lippincott-
Raven, Philadelphia, PA, 1996, pp. 2111^2148.
[3] I. Kovesdi, D.E. Brough, J.T. Bruder, T.J. Wickham, Curr.
Biol. 8 (1997) 583^589.
[4] P. Gilardi, M. Courtney, A. Pavirani, M. Perricaudet, FEBS
Lett. 267 (1990) 60^62.
[5] M.A. Rosenfeld, W. Siegfried, K. Yoshimura, K. Yoneya-
ma, M. Fukayama, L.E. Stier, P.K. Pa«a«kko« , P. Gilardi, L.D.
Stratford-Perricaudet, M. Perricaudet, S. Jallat, A. Pavirani,
J.-P. Lecocq, R.G. Crystal, Science 252 (1991) 431^434.
[6] M.S. Horwitz, in: B.N. Fields (Ed.), Fields Virology, Lip-
pincott-Raven, Philadelphia, PA, 1996, pp. 2149^2171.
[7] R. Reichel, S.D. Neill, I. Kovesdi, M.C. Simon, P. Ray-
chaudhuri, J.R. Nevins, J. Virol. 63 (1989) 3643^3650.
[8] C.A. Jost, D. Ginsberg, W.G. Kaelin, Virology 220 (1996)
78^90.
[9] E. Querido, R.C. Marcellus, A. Lai, R. Charbonneau, J.G.
Teodoro, G. Ketner, P.E. Branton, J. Virol. 71 (1997) 3788^
3798.
[10] M. Strauss, J. Lukas, J. Bartek, Nat. Med. 1 (1995) 1245^
1246.
[11] S. Herwig, M. Strauss, Eur. J. Biochem. 246 (1997) 581^601.
[12] R.A. Weinberg, Cell 81 (1995) 323^330.
[13] S.W. Hiebert, S.P. Chellappan, J.M. Horowitz, J.R. Nevins,
Genes Dev. 6 (1992) 177^185.
[14] S.J. Weintraub, K.N. Chow, R.X. Luo, S.H. Zhang, S. He,
D.C. Dean, Nature 375 (1995) 812^815.
[15] C.J. Sherr, Cell 73 (1993) 1059^1065.
[16] D.G. Johnson, J.K. Schwarz, W.D. Cress, J.R. Nevins, Na-
ture 365 (1993) 349^352.
[17] A. Almasan, Y. Yin, R.E. Kelly, E.Y. Lee, A. Bradley, W.
Li, J.R. Bertino, G.M. Wahl, Proc. Natl. Acad. Sci. USA 92
(1995) 5436^5440.
[18] H.J. Huang, J.K. Yee, J.Y. Shew, P.L. Chen, R. Bookstein,
T. Friedmann, E.Y. Lee, W.H. Lee, Science 242 (1988)
1563^1566.
[19] D.A. Haas-Kogan, S.C. Kogan, D. Levi, P. Dazin, A.
T’Ang, Y.K. Fung, M.A. Israel, EMBO J. 14 (1995) 461^
472.
[20] J. Fueyo, C. Gomez-Manzano, W.K.A. Yung, T.J. Liu, R.
Alemany, T.J. McDonnell, X. Shi, J.S. Rao, V.A. Levin,
A.P. Kyritsis, Nat. Med. 4 (1998) 685^690.
[21] R.P. Wersto, E.R. Rosenthal, P.K. Seth, N.T. Eissa, R.E.
Donahue, J. Virol. 72 (1998) 9491^9502.
[22] K. Brand, R. Klocke, A. PoMling, D. Paul, M. Strauss, Gene
Ther. 6 (1999) 1054^1063.
[23] R. Shtrichman, T. Kleinberger, J. Virol. 72 (1998) 2975^
2982.
[24] R.C. Marcellus, J.N. Lavoie, D. Boivin, G.C. Shore, G.
Ketner, P.E. Branton, J. Virol. 72 (1998) 7144^7153.
[25] J.N. Lavoie, M. Nguyen, R.C. Marcellus, P.E. Branton,
G.C. Shore, J. Cell Biol. 140 (1998) 637^645.
[26] W.S. El-Deiry, T. Tokino, V.E. Velculescu, D.B. Levy, R.
Parsone, J.M. Trent, D. Lin, W.E. Mercer, K.W. Kinzler, B.
Vogelstein, Cell 75 (1993) 817^825.
[27] V. Dulic, W.K. Kaufmann, S.J. Wilson, T.D. Tisty, E. Lees,
J.W. Harper, S.J. Elledge, S.I. Reed, Cell 76 (1994) 1013^
1023.
[28] M. Kobayashi, Y. Yamauchi, A. Tanaka, Exp. Cell Res. 239
(1998) 40^49.
[29] J.J. Swenson, A.E. Mauser, W.K. Kaufmann, S.C. Kenney,
J. Virol. 73 (1999) 6540^6550.
[30] R.J. Slebos, M.H. Lee, B.S. Plunkett, T.D. Kessis, B.O. Wil-
liams, T. Jacks, L. Hedrick, M.B. Kastan, K.R. Cho, Proc.
Natl. Acad. Sci. USA 91 (1994) 5320^5324.
[31] P. Michieli, M. Chedid, D. Lin, J.H. Pierce, W.E. Mercer, D.
Givol, Cancer Res. 54 (1994) 3391^3395.
[32] J.A. DeCaprio, J.W. Ludlow, J. Figge, J.-Y. Shew, C.-M.
Huang, W.-H. Lee, E. Marsilio, E. Paucha, D.M. Living-
stone, Cell 54 (1988) 275^283.
[33] K. Mu«nger, B.A. Werness, N. Dyson, W.C. Phelps, E. Har-
low, P.M. Howley, EMBO J. 8 (1989) 4099^4105.
[34] C. Egan, S.T. Bayley, P.E. Branton, Oncogene 4 (1989) 383^
388.
[35] V. Karantza, A. Maroo, D. Fay, J.M. Sedivy, Mol. Cell.
Biol. 13 (1993) 6640^6652.
[36] P.M. Flatt, L.J. Tang, C.D. Scatena, S.T. Szak, J.A. Pieten-
pol, Mol. Cell. Biol. 20 (2000) 4210^4223.
BBAMCR 14822 5-2-02
H. Kuhn et al. / Biochimica et Biophysica Acta 1542 (2002) 106^115114
[37] T. Waldman, K.W. Kinzler, B. Vogelstein, Cancer Res. 55
(1995) 5187^5190.
[38] J. Lukas, B.O. Petersen, K. Holm, J. Bartek, K. Helin, Mol.
Cell. Biol. 16 (1996) 1047^1057.
[39] X. Leng, L. Connel-Crowley, D. Goodrich, J.W. Harper,
Curr. Biol. 7 (1997) 709^712.
[40] W. Krek, M.E. Ewen, S. Shirodkar, Z. Arany, W.G. Kaelin
Jr., D.M. Livingston, Cell 78 (1994) 161^172.
[41] M. Xu, K.A. Sheppard, C.Y. Peng, A.S. Yee, H. Piwnica-
Worms, Mol. Cell. Biol. 14 (1994) 8420^8431.
[42] W. Krek, G. Xu, D.M. Livingston, Cell 83 (1995) 1149^
1158.
[43] Y.-B. Dong, H.-L. Yang, M.J. Elliott, T.-J. Liu, A. Stilwell,
C. Atienza Jr., K.M. McMasters, Cancer 86 (1999) 2021^
2033.
[44] B. Vogelstein, K.W. Kinzler, Cell 70 (1992) 523^526.
[45] S.L. Elledge, Science 274 (1996) 1664^1672.
[46] M. Rieber, M. Strasberg-Rieber, Int. J. Cancer 76 (1998)
757^760.
BBAMCR 14822 5-2-02
H. Kuhn et al. / Biochimica et Biophysica Acta 1542 (2002) 106^115 115
